Navigation Links
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Date:5/4/2009

- Ironwood Will Receive Up To $55 Million in Near Term Payments -

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that the company has entered into an out-licensing agreement with Laboratorios Almirall, S.A. for European rights to develop and commercialize the investigational compound linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and other gastrointestinal conditions. This agreement is a continuation of Ironwood's strategy to develop and market its products in the United States while forming partnerships to accelerate delivery to patients in other territories.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081006/NEM080ALOGO )

Under the terms of the agreement, Almirall will provide Ironwood with up to $55 million in near-term payments, including a $40 million upfront licensing fee. Pre-commercial licensing fees and milestone payments total $95 million. In addition, Ironwood will receive escalating royalties on linaclotide sales. Almirall will be responsible for activities relating to regulatory approval and commercialization, as well as expenses for the European market. Ironwood continues to retain all rights to linaclotide outside of North America and Europe.

"We are very pleased to be joining forces with Almirall to develop and commercialize linaclotide for the millions of patients in Europe who suffer from IBS-C and currently lack adequate therapies. Almirall presented us with the best strategy to rapidly and effectively deliver linaclotide to the market, and terms that, should linaclotide meet our expectations, allow us to share approximately half of the long term value of the product," said Peter Hecht, Ironwood's chief executive office
'/>"/>

SOURCE Ironwood Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
5. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  EnteroMedics Inc. (NASDAQ: ETRM ), a developer ... treat obesity, metabolic diseases, and other gastrointestinal disorders, announced ... 40,229,886 units. Each unit consists of one share of ... purchase one share of common stock, and 0.50 of ... common stock, at a purchase price of $0.87 per ...
(Date:6/30/2015)... Calif. and COPENHAGEN, Denmark ... Inc. , a global leader in clinical and commercial ... today that, as part of its global manufacturing capacity ... North American manufacturing facility in Bothell, Washington ... 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists of six ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... Cepheid (Nasdaq: CPHD ) today announced that ... Vice President of Infectious Disease Research and Development, reporting ... offers an impressive menu of eleven highly regarded Xpert® ... aggressively to extend our leadership with next-generation products, including ...
... 2011 In a recent announcement by Neurelis, ... positive clinical results in a Phase I pharmacokinetic ... at Particle Sciences.  In the Phase 1 clinical ... that reported in the literature for Diastat® (rectal ...
Cached Medicine Technology:Cepheid Appoints Vice President of Infectious Disease Research & Development 2Cepheid Appoints Vice President of Infectious Disease Research & Development 3Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) 2
(Date:6/30/2015)... ... June 30, 2015 , ... After more than five years of research ... GlobalSun (TM) — sunscreen specifically formulated for the unique skin of all people of ... the market just in time to help protect the skin of all people of ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood ... contest today. Why We Care Youth serves as a platform for young people living ... meant to them, and why U.S. policymakers should care about expanding access around the ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Tumor Center, has joined Allegheny Health Network (AHN) as Director of ... involve the management of primary brain tumors, brain metastases, leptomeningeal disease and the ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Citizens Commission on ... (D-IL) for writing to the Department of Health and Human Services (HHS), requesting ... system, Universal Health Services (UHS).[1] CCHR is expanding its seven-year review of UHS ...
(Date:6/30/2015)... AZ (PRWEB) , ... June 30, 2015 , ... ... announces that Ellen D. Wagner, Chief Research and Strategy Officer at Predictive Analytics ... Education at the National Science Foundation (NSF), will provide keynote addresses at the ...
Breaking Medicine News(10 mins):Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3
... A new poll of AARP members released today finds ... health care reform included in the Affordable Health Care for ... The AARP-backed bill limits how much more insurance companies can ... drug doughnut hole. , Among AARP members, strong majorities ...
... KUNMING, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- ... Shenghuo" or,the "Company"), which is engaged in the research, ... products,in the People,s Republic of China ("PRC"), today reported ... 2009. , , Third Quarter 2009 ...
... steer clear of low-fat meal plans, study says , ... may work better than a low-fat regimen for people ... them at higher risk for cardiovascular disease, new research ... confirms that the current recommendations are appropriate," said Alice ...
... the normal cells that surround cancer cells within and ... increase the effectiveness of traditional anti-cancer treatments, say researchers ... of Clinical Investigation published online November 16, they ... expressed by one type of these so-called "stromal" cells, ...
... to improve diagnosis and monitoring of Alzheimer,s disease, scientists ... a fast and accurate method for quantifying subtle, sub-regional ... study will be published the week of November 16 ... Sciences ( PNAS ). By applying the ...
... If cost-cutting U.S. Preventive Services Task Force ... decades of decline in breast cancer mortality could ... needlessly from breast cancer each year. The recommendations ... no medical imaging representation ─ would advise against ...
Cached Medicine News:Health News:Survey Finds AARP Members Back Health Care Reform Legislation 2Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 2Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 3Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 4Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 5Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 6Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 7Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 8Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 9Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 10Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 11Health News:Moderate-Fat Diet May Be Better at Reducing Heart Risks 2Health News:Moderate-Fat Diet May Be Better at Reducing Heart Risks 3Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 2Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 3Health News:Analyzing structural brain changes in Alzheimer's disease 2Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 2Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 3
... The table-mounted hip ... hands-free exposure for total ... to accommodate individual surgeon ... of any size. Hand-held ...
... gelatinase-associated lipocalin, lipocalin-2) is a new early ... renal failure with a >90% positive predictive ... urine, as early as 2 hours after ... diagnostic marker for acute renal failure. ,Quantitative ...
... "Beautiful tissue is how one neurosurgeon describes ... Needle. By "beautiful he means a,cleaner cut ... are,functions of the needles optimized vacuum and ... captive locking thumb nut holds vacuum,in the ...
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
Medicine Products: